wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q40640808-88E4F645-ABB0-476B-BFDE-5253DBBF7C6B
Q40640808-88E4F645-ABB0-476B-BFDE-5253DBBF7C6B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40640808-88E4F645-ABB0-476B-BFDE-5253DBBF7C6B
PARP Inhibitor Activity Correlates with SLFN11 Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung Cancer.
P2860
Q40640808-88E4F645-ABB0-476B-BFDE-5253DBBF7C6B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40640808-88E4F645-ABB0-476B-BFDE-5253DBBF7C6B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
777327366aa8b41ab2f4fddb5bb44c925349b285
P2860
Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation-Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105